Goldberg Michael J MD is categorized under Physicians Offices in Tarzana, CA and active since 1996.
Goldberg Michael J MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Goldberg at the company’s single location by writing to 5620 Wilbur Avenue # 318, Tarzana, California CA 91356 or by phoning (818) 343-1010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Goldberg Michael J MD |
| Contact Person: | Michael Goldberg |
| Address: | 5620 Wilbur Avenue # 318, Tarzana, California 91356 |
| Phone Number: | (818) 343-1010 |
| Website Address: | neuroimmunedr.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Goldberg Michael J MD was started in 1996 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Goldberg for inquiries that concern Goldberg Michael J MD by calling the company number (818) 343-1010, as your correspondence is most welcome. Additionally, the physical location of the single location of Goldberg Michael J MD can be found at the coordinates 34.172766,-118.54466 as well as the street address 5620 Wilbur Avenue # 318 in Tarzana, California 91356.
For its online presence, you may visit Goldberg Michael J MD’s website at neuroimmunedr.com and engage with its social media outlets through on Twitter and on Facebook.